Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Immaculate Nankya

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
The Lancet. HIV|May 13, 2017
Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trialNicholas I Paton, Cissy Kityo, Jennifer Thompson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 28, 2017
HIV Drug Resistance Mutations in Non-B Subtypes After Prolonged Virological Failure on NNRTI-Based First-Line Regimens in Sub-Saharan AfricaCissy Kityo, Jennifer Thompson, Immaculate Nankya, et al.
Infectious Diseases of Poverty|December 6, 2017
Sensitive detection of HIV-1 resistance to Zidovudine and impact on treatment outcomes in low- to middle-income countriesRichard M Gibson, Gabrielle Nickel, Michael Crawford, et al.
AIDS Research and Human Retroviruses|January 3, 2016
HIV Drug Resistance Among Children Initiating First-Line Antiretroviral Treatment in UgandaCissy Kityo, Kim Catherina Eve Sigaloff, Tamara Sonia Boender, et al.
AIDS Research and Human Retroviruses|March 23, 2013
Short communication: high rates of thymidine analogue mutations and dual-class resistance among HIV-infected Ugandan children failing first-line antiretroviral therapyKim C E Sigaloff, Joshua Kayiwa, Victor Musiime, et al.
The Journal of Antimicrobial Chemotherapy|August 28, 2020
Accumulation of integrase strand transfer inhibitor resistance mutations confers high-level resistance to dolutegravir in non-B subtype HIV-1 strains from patients failing raltegravir in UgandaEmmanuel Ndashimye, Mariano Avino, Abayomi S Olabode, et al.
Ebiomedicine|October 19, 2016
Infecting HIV-1 Subtype Predicts Disease Progression in Women of Sub-Saharan AfricaColin M Venner, Immaculate Nankya, Fred Kyeyune, et al.
Plos Pathogens|January 19, 2018
Higher sequence diversity in the vaginal tract than in blood at early HIV-1 infectionKatja Klein, Gabrielle Nickel, Immaculate Nankya, et al.
AIDS (London, England)|April 12, 2016
Once vs twice-daily abacavir and lamivudine in African childrenVictor Musiime, Philip Kasirye, Bethany Naidoo-James, et al.
Retrovirology|January 16, 2022
Reduced and highly diverse peripheral HIV-1 reservoir in virally suppressed patients infected with non-B HIV-1 strains in UgandaSamira Joussef-Piña, Immaculate Nankya, Sophie Nalukwago, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
The Lancet. HIV|May 13, 2017
Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trialNicholas I Paton, Cissy Kityo, Jennifer Thompson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 28, 2017
HIV Drug Resistance Mutations in Non-B Subtypes After Prolonged Virological Failure on NNRTI-Based First-Line Regimens in Sub-Saharan AfricaCissy Kityo, Jennifer Thompson, Immaculate Nankya, et al.
Infectious Diseases of Poverty|December 6, 2017
Sensitive detection of HIV-1 resistance to Zidovudine and impact on treatment outcomes in low- to middle-income countriesRichard M Gibson, Gabrielle Nickel, Michael Crawford, et al.
AIDS Research and Human Retroviruses|January 3, 2016
HIV Drug Resistance Among Children Initiating First-Line Antiretroviral Treatment in UgandaCissy Kityo, Kim Catherina Eve Sigaloff, Tamara Sonia Boender, et al.
AIDS Research and Human Retroviruses|March 23, 2013
Short communication: high rates of thymidine analogue mutations and dual-class resistance among HIV-infected Ugandan children failing first-line antiretroviral therapyKim C E Sigaloff, Joshua Kayiwa, Victor Musiime, et al.
The Journal of Antimicrobial Chemotherapy|August 28, 2020
Accumulation of integrase strand transfer inhibitor resistance mutations confers high-level resistance to dolutegravir in non-B subtype HIV-1 strains from patients failing raltegravir in UgandaEmmanuel Ndashimye, Mariano Avino, Abayomi S Olabode, et al.
Ebiomedicine|October 19, 2016
Infecting HIV-1 Subtype Predicts Disease Progression in Women of Sub-Saharan AfricaColin M Venner, Immaculate Nankya, Fred Kyeyune, et al.
Plos Pathogens|January 19, 2018
Higher sequence diversity in the vaginal tract than in blood at early HIV-1 infectionKatja Klein, Gabrielle Nickel, Immaculate Nankya, et al.
AIDS (London, England)|April 12, 2016
Once vs twice-daily abacavir and lamivudine in African childrenVictor Musiime, Philip Kasirye, Bethany Naidoo-James, et al.
Retrovirology|January 16, 2022
Reduced and highly diverse peripheral HIV-1 reservoir in virally suppressed patients infected with non-B HIV-1 strains in UgandaSamira Joussef-Piña, Immaculate Nankya, Sophie Nalukwago, et al.
Pageof 4